Coloplast A/S is a publicly traded company trading on OTC, led by CEO Lars Soren Rasmussen.
Upcoming earnings announcement for Coloplast A/S
Past 12 earnings reports for Coloplast A/S
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Q1 2026 | $0.09Est: $0.09 | 0.0% | $1.1B | — | — |
| Nov 4, 2025 | Q4 2025 | $0.07 | — | $1.1B | — | — |
| Aug 19, 2025 | Q3 2025 | $0.06 | — | $1.1B | — | — |
| May 6, 2025 | Q2 2025 | $0.06 | — | $976.6M | — | — |
| Feb 4, 2025 | Q1 2025 | $0.07Est: $0.08 | -12.5% | $1.0BEst: $976.4M | +2.9% | — |
| Nov 5, 2024 | Q4 2024 | $0.08 | — | $1.0B | — | — |
| Aug 20, 2024 | Q3 2024 | $0.08 | — | $993.5M | — | — |
| May 7, 2024 | Q2 2024 | $0.08 | — | $959.1M | — | — |
| Feb 9, 2024 | Q1 2024 | $0.08 | — | $953.3M | — | — |
| Nov 9, 2023 | Q4 2023 | $0.08 | — | $909.1M | — | — |
| Aug 17, 2023 | Q3 2023 | $0.09 | — | $892.6M | — | — |
| May 11, 2023 | Q2 2023 | $0.08 | — | $873.6M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.